Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway
2022

Retraction of Study on Ovarian Cancer and Cisplatin Resistance

publication

Author Information

Author(s): Peng Wang, Yuanjing Hu, Pengpeng Qu, Ying Zhao, Jing Liu, Jianguo Zhao, Beihua Kong

Conclusion

The article has been retracted due to concerns about the integrity of the data.

Supporting Evidence

  • The article was retracted due to concerns about data integrity.
  • The authors were unable to provide original data in the appropriate format.

Takeaway

The study that claimed a specific protein helps ovarian cancer patients resist a drug has been taken back because the authors couldn't prove their findings.

Digital Object Identifier (DOI)

10.1080/21655979.2021.2022268

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication